Which is More Effective in Management of Bruxism: Botox or Occlusal Splints
- Conditions
- Bruxism
- Interventions
- Registration Number
- NCT04366869
- Lead Sponsor
- October University for Modern Sciences and Arts
- Brief Summary
The aim of this study is to compare the efficacy of Botulinum toxin (Botox) and traditional occlusal splints for the management of bruxism in edentulous patients rehabilitated with MIOD
- Detailed Description
42 edentulous patients having implant retained mandibular overdenture suffering from bruxism with clinical manifestation, will be randomly divided into three groups, group 1 control group (traditional approach of removing denture at night) ,group 2 will be managed by occlusal splints whereas group 3 will be managed with botulinum toxin injection (Botox). New maxillary dentures and mandibular over dentures will be constructed for both groups. Muscle activity will be measured at time of denture insertion (T0), 3(T3) 6(T6), 9(T9) and 12(T12) month of treatment. Patients satisfaction will be evaluated at the time of denture insertion (T0), 6(T6), and 12(T12) month of treatment using TMD/ NS numeric scales 10 cm questionnaire which include: headache, face pain, face tension, limitation of mouth opening and complaints during mastication.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
- patients diagnosed with bruxism
- patients had mandibular implant retained overdentures within the previous 3 years
- cooperative patients
- physically and psychologically able patients to tolerate the procedure
- patients taking muscle relaxants
- patients without neuromuscular control
- poor oral hygiene
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description control overdenture traditional approach of removing denture at night intervention 1 occlusal splint occlusal splint intervention 2 Botox Botox
- Primary Outcome Measures
Name Time Method Patient satisfaction: questionnaire 12months Patients satisfaction was evaluated using TMD/ NS numeric scales 10 cm questionnaire which included: headache, face pain, face tension, limitation of mouth opening and complaints during mastication with scores from 1 to 10 whereas 1 means least pain and 10 means highest pain.it was assessed at baseline (T0), then after 3months(T3) then after 6months from baseline(T6), then after 9months from baseline(T9) and finally after 12 months from baseline (T12). which means every 3 months.
- Secondary Outcome Measures
Name Time Method Electromyography 12 months measuring muscle activity for massetter and temporalis muscle at baseline,3,6,9,12 months
Trial Locations
- Locations (1)
MSA
🇪🇬Giza, Egypt